七味白术散加减治疗肠易激综合征脾胃虚弱证的临床观察
2016-01-22吴成建
吴成建
【摘 要】 目的:探讨七味白术散加减治疗肠易激综合征脾胃虚弱证的临床疗效。方法:随机选择我院自2013年7月至2014年6月收治的73例肠易激综合征脾胃虚弱证患者的临床资料,根据数字随机分配的原则,将患者分为治疗组37例与对照组36例,治疗组患者给予七味白术散加减治疗,对照组患者给予口服黄连素。对比观察两组患者临床疗效。结果:经治疗后观察发现,治疗组患者总有效率100%,对照组88.9%,两组患者总有效率比较,结果具有明显差异(P<0.05),予全部患者为期1年时间随访,观察发现,治疗组患者复发率8.1%,对照组患者复发率22.2%,两组患者复发率比较,结果具有明显差异(P<0.05)。结论:七味白术散加减治疗肠易激综合征脾胃虚弱证疗效确切,复发率低,可临床推广应用。
【关键词】 七味白术散 肠易激综合征 脾胃虚弱证
【Abstract】 Objective: To investigate the clinical curative effect of spleen stomach deficiency of seven kinds of powder Decoction for the treatment of irritable bowel syndrome. Methods: random selection in our hospital from July 2013 to 2014 June were 73 cases of irritable bowel syndrome of spleen stomach deficiency syndrome in patients with clinical data, according to the principle of digital random distribution, patients were randomly divided into treatment group of 37 cases with the control group (36 cases), patients in the treatment group were treated with modified Qiwei Baizhu powder treatment, the control group were treated with oral administration of berberine. To observe the clinical effect of the two groups of patients. Results: after treatment, the total effective rate was 100% in treatment group and 88.9% in control group. The results were significantly different (P<0.05). The recurrence rate was 8.1% in treatment group and 22.2% in control group. The recurrence rate was two in control group, and the recurrence rate was two. The results showed significant difference (P<0.05). Conclusion: Qiwei Baizhu Decoction for the treatment of irritable bowel syndrome of the weakness of the spleen and stomach syndrome curative effect, low recurrence rate, clinical application.
【Key words】 seven flavor powder; irritable bowel syndrome; spleen and stomach deficiency
肠易激综合征腹泻型是一组包括腹胀、腹痛、排便增多、大便性状异常在内的功能性胃肠疾病,属中医“泄泻”范畴。其症状表现为反复持续性发作,腹泻、腹痛多于晨起发作,进食和精神紧张时易诱发。患者情绪问题也会诱发肠易激综合征[1]。其病理生理基础为胃肠动力学异常,目前西医尚无特效药物,多以对症处理为主。本组研究中,随机选择我院自2013年7月至2014年6月收治的73例肠易激综合征脾胃虚弱证患者的临床资料,通过采用七味白术散加减治疗肠易激综合征脾胃虚弱证,取得较满意的效果,现将结果报告如下。
1 资料与方法
1.1 一般资料
随机选择我院自2013年7月至2014年6月收治的73例肠易激综合征脾胃虚弱证患者的临床资料,据数字随机分配的原则,将患者分为治疗组37例与对照组36例,其中对照组患者采用口服黄连素治疗,该组中男性15例,女性21例;患者年龄分布在22~60岁之间,患者平均年龄(40.4±7.4)岁;……